2020
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression
Li W, Zhao J, Ding K, Chao HH, Li CR, Cheng H, Shen L. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression. Medical Science Monitor 2020, 26: e923567-1-e923567-10. PMID: 32985495, PMCID: PMC7531203, DOI: 10.12659/msm.923567.Peer-Reviewed Original ResearchConceptsBreast cancer patientsHormonal receptor expressionCancer patientsReceptor expressionMemory impairmentProgesterone receptorBreast cancerEstrogen receptorG genotypeGene polymorphismsCognitive impairmentRisks of chemotherapyBreast cancer survivorsSingle nucleotide polymorphismsProspective memory impairmentCatechol-O-methyltransferase gene polymorphismExtent of deficitsMemory scoresER-/PRBDNF polymorphismCancer survivorsCognitive dysfunctionChemotherapyPatientsCognitive deficits
2018
Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer
Cheng H, Chen H, Lv Y, Chen Z, Li C. Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer. Cancer Medicine 2018, 7: 5315-5321. PMID: 30259694, PMCID: PMC6198199, DOI: 10.1002/cam4.1784.Peer-Reviewed Original ResearchConceptsDigit span testVerbal fluency testProspective memory impairmentMini-Mental State ExaminationTime-based prospective memory taskMemory impairmentProspective memory taskCognitive neuropsychological testsWhole brain radiotherapyMetastatic brain cancerMemory taskSpan testFluency testNeuropsychological testsBrain cancerState ExaminationBrain metastasesBrain radiotherapyCancer patientsImpairmentNonsignificant decreasePatientsTBPMRadiotherapyTask